GSK PLC (GSK)
45.07
+0.40
(+0.90%)
USD |
NYSE |
May 10, 16:00
45.07
0.00 (0.00%)
After-Hours: 20:00
GSK Revenue (TTM): 38.64B for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 38.64B |
| December 31, 2023 | 37.75B |
| September 30, 2023 | 36.42B |
| June 30, 2023 | 35.32B |
| March 31, 2023 | 35.05B |
| December 31, 2022 | 36.24B |
| September 30, 2022 | 37.11B |
| June 30, 2022 | 37.03B |
| March 31, 2022 | 36.48B |
| December 31, 2021 | 37.06B |
| September 30, 2021 | 26.20B |
| June 30, 2021 | 28.23B |
| March 31, 2021 | 29.53B |
| December 31, 2020 | 30.95B |
| September 30, 2020 | 43.74B |
| June 30, 2020 | 44.13B |
| March 31, 2020 | 44.71B |
| December 31, 2019 | 43.04B |
| September 30, 2019 | 42.13B |
| June 30, 2019 | 41.10B |
| March 31, 2019 | 41.03B |
| December 31, 2018 | 41.09B |
| September 30, 2018 | 40.69B |
| June 30, 2018 | 40.41B |
| March 31, 2018 | 39.81B |
| Date | Value |
|---|---|
| December 31, 2017 | 38.91B |
| September 30, 2017 | 38.19B |
| June 30, 2017 | 37.83B |
| March 31, 2017 | 37.86B |
| December 31, 2016 | 37.63B |
| September 30, 2016 | 37.74B |
| June 30, 2016 | 37.33B |
| March 31, 2016 | 36.96B |
| December 31, 2015 | 36.57B |
| September 30, 2015 | 36.82B |
| June 30, 2015 | 36.75B |
| March 31, 2015 | 37.09B |
| December 31, 2014 | 37.86B |
| September 30, 2014 | 39.25B |
| June 30, 2014 | 39.92B |
| March 31, 2014 | 40.73B |
| December 31, 2013 | 41.49B |
| September 30, 2013 | 41.23B |
| June 30, 2013 | 41.44B |
| March 31, 2013 | 41.51B |
| December 31, 2012 | 41.88B |
| September 30, 2012 | 41.93B |
| June 30, 2012 | 43.06B |
| March 31, 2012 | 43.80B |
| December 31, 2011 | 43.92B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
26.20B
Minimum
Sep 2021
44.71B
Maximum
Mar 2020
37.04B
Average
37.05B
Median
Revenue (TTM) Benchmarks
| AstraZeneca PLC | 47.61B |
| Novo Nordisk A/S | 35.54B |
| Pfizer Inc | 55.09B |
| Sanofi SA | 50.69B |
| Haleon PLC | 14.13B |